These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 4394469)

  • 21. Studies on the effect of cyclophosphamide on Yoshida sarcoma ascites cells implanted into the colon wall of rats.
    Bhide S; Habs M; Reinhold H; Schmähl D
    Arzneimittelforschung; 1979; 29(3):477-9. PubMed ID: 582732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The selectivity of action of alkylating agents and drug resistance. I. Biochemical changes occurring in sensitive and resistant strains of the Yoshida ascites sarcoma following chemotherapy.
    Harrap KR; Hill BT
    Br J Cancer; 1969 Mar; 23(1):210-26. PubMed ID: 5768437
    [No Abstract]   [Full Text] [Related]  

  • 23. Host resistance against tumor and its synergic effect with cancer chemotherapy.
    Sato R
    Gan; 1967 Jun; 58(3):211-20. PubMed ID: 6081225
    [No Abstract]   [Full Text] [Related]  

  • 24. Cytotoxic effects of snake venoms on KB and Yoshida sarcoma cells.
    Tu AT; Giltner JB
    Res Commun Chem Pathol Pharmacol; 1974 Dec; 9(4):783-6. PubMed ID: 4456506
    [No Abstract]   [Full Text] [Related]  

  • 25. Cytochemical characterization of Yoshida sarcoma cells resistant to dibromodulcitol.
    Gáti E; Pokorny E; Somfai-Relle S; Szentirmay Z
    Int J Tissue React; 1984; 6(1):43-51. PubMed ID: 6715118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Chemotherapy of murine Ehrlich carcinoma and rat Yoshida sarcoma transplanted on hamsters].
    Ondrus B; Oravec C; Cambelová J; Mériová M
    Bratisl Lek Listy; 1970 Sep; 54(3):262-74. PubMed ID: 5475862
    [No Abstract]   [Full Text] [Related]  

  • 27. Change in immunosensitivity of Yoshida sarcoma produced by chemical modification of cell-surface membrane.
    Iwaguchi T; Hozumi T
    Gan; 1975 Apr; 66(2):155-8. PubMed ID: 1150008
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anticancer potential of N,N-diethylaminoethyl ethers of flavanone oximes: a comparison with mitoxantrone action on rat Yoshida sarcoma cells in vivo.
    Metodiewa D; Kochman A; Koceva-Chyła A
    Anticancer Res; 1999; 19(2A):1249-54. PubMed ID: 10368684
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibitory effect of combined administration with CPT-11 and 5-fluorouracil in vitro and in vivo.
    Satoh H; Ohtomo M; Ishikawa H; Kamma H; Ohtsuka M; Hasegawa S
    Cancer Biochem Biophys; 1999 Jul; 17(1-2):59-67. PubMed ID: 10738902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolation and characterization of nitrogen mustard-sensitive cells from a nitrogen mustard-resistant subline of Yoshida sarcoma.
    Isaka H; Izumitani M; Moriwaki A; Sakurai Y
    Gan; 1966 Aug; 57(4):353-66. PubMed ID: 5969489
    [No Abstract]   [Full Text] [Related]  

  • 31. Studies on two variant strains of Yoshida sarcoma characterized by island formation in ascites.
    Ishidate M; Isaka H
    Gan; 1966 Aug; 57(4):413-26. PubMed ID: 5338890
    [No Abstract]   [Full Text] [Related]  

  • 32. [Experimental investigations on the action of local warming in tumor therapy with cytostatics in hypothermia].
    Magdon E
    Zentralbl Chir; 1965; 90(26):1381-5. PubMed ID: 5883357
    [No Abstract]   [Full Text] [Related]  

  • 33. The cancerostatic effects of some isothiocyanates on nitrogen mustard-sensitive and -resistant lines of Yoshida sarcoma.
    Miko M; Ujházy V
    Neoplasma; 1968; 15(4):357-63. PubMed ID: 5684461
    [No Abstract]   [Full Text] [Related]  

  • 34. [Enhancement of 5-fluorouracil (5-FU) antitumor effect of amino acid solution (methionine deprived amino acid solution: AO-90) in 5-FU-resistant Yoshida sarcoma].
    Hibino Y; Kawarabayashi Y; Kuwahata T; Ueda N; Shinguu H
    Gan To Kagaku Ryoho; 1991 May; 18(6):1055-7. PubMed ID: 2029192
    [No Abstract]   [Full Text] [Related]  

  • 35. Lytic agents, cell permeability, and monolayer penetrability.
    Salton MR
    J Gen Physiol; 1968 Jul; 52(1):227Suppl-52s. PubMed ID: 4913700
    [No Abstract]   [Full Text] [Related]  

  • 36. A mitomycin C-resistant Jensen rat sarcoma: chemotherapy studies.
    Sugiura K; Merker PC
    Cancer Res; 1963 Sep; 23(8 Pt 2):1475-82. PubMed ID: 5878213
    [No Abstract]   [Full Text] [Related]  

  • 37. [Experiments on the treatment of Yoshida tumor with neuroaminidase of Vibrio cholerae].
    Sánchez Cousteau JA; Justo Alpañes E; Ledro Molina D; Ferreiro Madueño M; Gomez Parra M; Ramírez Martínez R; Valle Bernal MJ; Astolfi Pérez de Guzmán J; Garrido Peralta M
    Rev Clin Esp; 1979 Sep; 154(5):183-6. PubMed ID: 523718
    [No Abstract]   [Full Text] [Related]  

  • 38. [Tumour inhibitory N-(bis--(2-chlorethyl)-aminomethyl)-urethanes (author's transl)].
    Schïnenberger H; Schmidt F; Bindl L
    Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1975 Nov; 84(3):277-40. PubMed ID: 128219
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antitumor effect of 2-thio-4-hydrazinouracil on transplantable tumors.
    Golovinsky EV; Emanuilov EA; Spassovska NC; Spassov AV
    Neoplasma; 1975; 22(3):255-8. PubMed ID: 1161120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Increase in the generation of superoxide radicals and in the inhibitory effect on Yoshida sarcoma of anthracycline antitumor agents by ultrasound].
    Yumita N; Nishigaki R; Umemura K; Umemura S
    Nihon Gan Chiryo Gakkai Shi; 1989 Jan; 24(1):63-8. PubMed ID: 2544650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.